- DermTech has created a patch to disrupt the skin cancer detection market. The patch is placed on the skin for a few seconds to collect RNA.
- Currently, they are only working to fight melanoma and skin cancer, but they are also trying to slowly expand into new types of skin cancer.
- They are beating traditional methods in price, accuracy, and simplicity, which makes DermTech's product very appealing.
- Despite this, there are risks about valuation, commercialization, and DermTech's financials that give me pause.
For further details see:
DermTech: Disrupting Skin Cancer Testing